Panacea Announces Effectiveness of Registration Statement for Proposed Business Combination with Nuvation Bio
(WorldNews Business)

SAN FRANCISCO--(BUSINESS WIRE)--Jan 20, 2021-- Panacea Acquisition Corp., a Delaware corporation (the “Company”) (NYSE: PANA.U, PANA, PANA WS), announced today that its registration statement on Form S-4 (File No. 333-250036) (as amended, the “Registration Statement”), relating to the previously announced business combination (the “Business Combination”) with Nuvation Bio Inc. (“Nuvation Bio”), has been declared effective by the U.S. Securities and Exchange Commission (“SEC”) and that it has commenced mailing the definitive proxy statement/prospectus relating to the Special Meeting (the “Special Meeting”) of the Company`s stockholders to be held on February 9, 2021 in connection with the...